Stay updated on Avelumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Solid Tumors Clinical Trial page.

Latest updates to the Avelumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a Locations section with state-level entries (Arizona, Arkansas, California, District of Columbia, Florida, Georgia, Illinois, Indiana, Maryland, Michigan, Minnesota, Missouri, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Washington) and a Revision: v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2. No substantive changes to study details or page functionality are evident.SummaryDifference0.0%

- Check38 days agoChange DetectedA note has been added clarifying that publications are automatically filled from PubMed, and the revision label has been updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check46 days agoChange DetectedDifference0.2%

- Check60 days agoChange DetectedMinor cosmetic updates to the page layout and navigation with no changes to study design, eligibility criteria, primary outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check89 days agoChange DetectedSummary of changes: updated operating-status notice and added a new version tag (v3.2.0); removed the previously listed term 'Adrenal cortex carcinoma' and the older version 'v3.1.0'.SummaryDifference0.8%

Stay in the know with updates to Avelumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Solid Tumors Clinical Trial page.